9 Stocks With Bullish Institutional and Insider Buying Activities

After posting 3 S&P 500 Stocks With Significant Institutional and Insider Buying, we decided to run the screen again, but this time expand our universe to include all stocks with market caps above $300 million.

With respect to new readers, we used these two screens – institutional and insider buying – because their investment decisions are often the result of more information than the average investor.

Insiders, naturally, work at the companies in question and have more knowledge about the firm than outsiders. When they put their own money on the line to purchase their company’s shares it indicates they are bullish about the firm’s future, and believe current share price is undervalued. Likewise, institutions have more sophisticated market data than the average main street investor, and their purchase decisions presumably come after careful analytical work.

Business Section: Investing Ideas

The following is a list of stocks, market caps above $300 million, with significant net institutional buying in the current quarter and insider buying in the last 6 months.

Use this list as a starting-off point for your own analysis.

Interactive Chart: Use the Compar-O-Matic to compare market caps for the stocks mentioned below:

1. Endeavour International Corporation (END, Earnings, Analysts, Financials): Engages in the acquisition, exploration, development, and production of crude oil and natural gas in the United States and the United Kingdom. Market cap at $386.78M, most recent closing price at $8.30. Net institutional purchases in the current quarter at 11.3M shares, which represents about 41.67% of the company’s float of 27.12M shares. Over the last six months, insiders were net buyers of 544,339 shares, which represents about 2.01% of the company’s 27.12M share float.

2. Genomic Health Inc. (GHDX, Earnings, Analysts, Financials): Focuses on the development and global commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Market cap at $1.05B, most recent closing price at $34.63. Net institutional purchases in the current quarter at 1.3M shares, which represents about 7.74% of the company’s float of 16.80M shares. Over the last six months, insiders were net buyers of 609,079 shares, which represents about 3.63% of the company’s 16.80M share float.

3. Heritage-Crystal Clean, Inc (HCCI, Earnings, Analysts, Financials): Provides industrial and hazardous waste services to small and mid-sized customers in the United States. Market cap at $314.49M, most recent closing price at $17.27. Net institutional purchases in the current quarter at 2.8M shares, which represents about 31.32% of the company’s float of 8.94M shares. Over the last six months, insiders were net buyers of 205,424 shares, which represents about 2.3% of the company’s 8.94M share float.

4. Hudson Pacific Properties, Inc. (HPP, Earnings, Analysts, Financials): Operates as a vertically integrated real estate company. Market cap at $915.12M, most recent closing price at $19.38. Net institutional purchases in the current quarter at 14.2M shares, which represents about 43.1% of the company’s float of 32.95M shares. Over the last six months, insiders were net buyers of 2,000,000 shares, which represents about 6.07% of the company’s 32.95M share float.

5. IMAX Corporation (IMAX, Earnings, Analysts, Financials): Operates as an entertainment technology company worldwide. Market cap at $1.45B, most recent closing price at $21.93. Net institutional purchases in the current quarter at 3.7M shares, which represents about 6.69% of the company’s float of 55.34M shares. Over the last six months, insiders were net buyers of 1,134,002 shares, which represents about 2.05% of the company’s 55.34M share float.

6. Kratos Defense & Security Solutions, Inc. (KTOS, Earnings, Analysts, Financials): Provides engineering, war fighter, security, and information technology services, solutions, and products in the United States. Market cap at $336.35M, most recent closing price at $5.95. Net institutional purchases in the current quarter at 2.9M shares, which represents about 6.55% of the company’s float of 44.26M shares. Over the last six months, insiders were net buyers of 11,127,500 shares, which represents about 25.14% of the company’s 44.26M share float.

7. Level 3 Communications Inc. (LVLT, Earnings, Analysts, Financials): Engages in the communications business in North America and Europe. Market cap at $5.04B, most recent closing price at $23.22. Net institutional purchases in the current quarter at 10.8M shares, which represents about 6.92% of the company’s float of 156.03M shares. Over the last six months, insiders were net buyers of 4,981,255 shares, which represents about 3.19% of the company’s 156.03M share float.

8. PROLOR Biotech, Inc. (PBTH, Earnings, Analysts, Financials): Engages in the development of proprietary versions of already-approved therapeutic proteins. Market cap at $329.1M, most recent closing price at $5.19. Net institutional purchases in the current quarter at 4.8M shares, which represents about 13.39% of the company’s float of 35.86M shares. Over the last six months, insiders were net buyers of 1,005,000 shares, which represents about 2.8% of the company’s 35.86M share float.

9. Synta Pharmaceuticals Corp. (SNTA, Earnings, Analysts, Financials): Focuses on the discovery, development, and commercialization of small molecule drug candidates for treating severe medical conditions, including cancer and chronic inflammatory diseases. Market cap at $560.27M, most recent closing price at $9.06. Net institutional purchases in the current quarter at 2.3M shares, which represents about 6.99% of the company’s float of 32.91M shares. Over the last six months, insiders were net buyers of 1,058,660 shares, which represents about 3.22% of the company’s 32.91M share float.